2018 Medicinal Chemistry Reviews
Case History: IDHIFA® (Enasidenib), a First-in-Class Selective IDH2 Inhibitor for the Treatment of Acute Myeloid Leukemia
Zenon D. Konteatis and Zhihua Sui
Ref. n°: REV2018-ch26
You must be connected to be able to download the pdf file of this chapter.